SVB Leerink Starts iTeos Therapeutics (ITOS) at Outperform
Tweet
Share
E-mailGet Alerts ITOS Hot Sheet
Price: $10.15 --0%
Rating Summary:
1 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
SVB Leerink analyst Daina Graybosch initiates coverage on iTeos Therapeutics (NASDAQ: ITOS) with a Outperform rating and a price target of $45.00.
For an analyst ratings summary and ratings history on iTeos Therapeutics click here. For more ratings news on iTeos Therapeutics click here.
Shares of iTeos Therapeutics closed at $32.92 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- UBS Starts Schrodinger (SDGR) at Neutral
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
